Skip to main content

Table 4 Distribution of drug resistance and VF genes among ESBL producers and non ESBLUPEC

From: Phylogeny, sequence-typing and virulence profile of uropathogenic Escherichia coli (UPEC) strains from Pakistan

Numbers and percentages of the isolates andtheir respective traits

Resistance traits

All isolates (n = 155); n(%)

Non ESBL producers (n = 90) n(%)

ESBL producers (n = 65) n(%)

p value

Piperacillin tazobactam

7(5)

4(4)

3(5)

> 0.9999

Ceftazidime

96(62)

36(40)

60(92)

< 0.0001

Cefotaxime

101(65)

40(44)

61(94)

< 0.0001

Ceftriaxone

99(64)

49(54)

50(77)

0.0040

Ciprofloxacin

95(61)

45(50)

50(77)

0.000684

Levofloxacin

97(63)

48(53)

49(75)

0.0051

Amikacin

7(5)

4(4)

3(5)

0.9597

Gentamicin

47(30)

30(33)

17(26)

0.3373

Amoxicillin-clavulanic acid

111(72)

50(56)

61(94)

< 0.0001

Trimethoprim sulfonamides

130(84)

67(74)

63(97)

0.0002

Nitrofurantoin

9(6)

6(7)

3(5)

0.5900

Fosfomycin

15(10)

8(9)

7(11)

0.6960

fimH

155 (100)

90 (100)

65 (100)

> 0.9999

papA

20 (13)

12 (13)

8 (12)

0.8509

papC

75 (48)

42 (47)

33 (51)

0.6140

papEF

37 (24)

18 (20)

19 (29)

0.1834

papGI

6 (4)

3 (3)

3 (5)

0.6831

papGII

70 (45)

33 (37)

37 (57)

0.0124

papGIII

6 (4)

4 (4)

2 (3)

0.6632

sfa/foc

20 (13)

11 (12)

9 (14)

0.7660

Afa

15 (10)

7 (8)

8 (12)

0.3466

bmaE

2 (1)

1 (1)

1 (2)

0.8246

fyuA

37 (24)

20 (22)

17 (26)

0.5710

iutA

86 (55)

45 (50)

41 (63)

0.1060

feoB

76 (49)

40 (44)

36 (55)

0.1788

kpsmtII

40 (26)

19 (21)

21 (32)

0.1160

kpsmtIII

4 (3)

2 (2)

2 (3)

0.4729

Usp

22 (14)

10 (9)

12 (18)

0.1957

hlyA

18 (12)

7 (8)

11 (17)

0.0795

cdtB

11 (7)

6 (7)

5 (8)

0.8062

  1. Distribution of resistance and virulence traits among ESBL and non-ESBL producing uropathogenic E. coli (N = 155). The p values were calculated by comparing different traits among ESBL producer’s and non-ESBL producers